台股 » 個股 » 杏國 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

杏國

(4192)
  • 股價
    45.80
  • 漲跌
    ▼1.05
  • 漲幅
    -2.24%
  • 成交量
    21
  • 產業
    上櫃 生技醫療類股▲0.73%
  • 119人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
杏國 (4192)籌碼相關-群益金鼎-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/3000.00247.9047.10-248-4.11%
2024/04/29249.4300.0048.202474.17%
2024/04/1100.000.151.0053.80-0.132-0.16%
2024/04/100.155.5000.0055.500.1240.21%
2023/09/0700.000.847.2549.30-0.832-2.44%
2023/07/3100.001.148.2249.20-1.143-2.46%
2023/06/2000.00216.8017.10-253-3.75%
2022/08/3000.00133.2033.20-179-1.26%
2022/08/26232.70132.8032.451771.28%
2022/08/19130.4000.0030.551561.76%
2022/05/20130.5000.0030.7013370.30%
2022/05/0600.00134.1535.00-1356-0.28%
2022/04/2700.00237.7037.30-2353-0.57%
2022/04/1800.00137.2037.00-1329-0.30%
2022/04/1200.00441.5039.25-4307-1.30%
2022/04/11444.1500.0043.6042971.35%
2022/03/31237.8000.0037.8022490.80%
2022/03/1500.00134.4534.20-1316-0.32%
2022/02/2500.00436.5838.10-4386-1.03%
2022/02/1500.00631.2531.10-6529-1.13%
2022/01/21629.3300.0029.0068610.70%
2022/01/20429.3000.0029.5548600.46%
2021/12/21131.8000.0031.8511,2530.08%
2021/12/1700.00532.7233.30-51,301-0.38%
2021/12/14136.8000.0035.2011,3620.07%
2021/12/13537.7300.0037.7551,3980.36%
2021/12/1000.00135.1035.00-11,457-0.07%
2021/12/03131.2500.0031.0511,4830.07%
2021/11/3000.00333.2032.90-31,499-0.20%
2021/11/25334.7000.0035.4531,5290.20%
2021/11/19134.9000.0035.2011,5650.06%
2021/11/18136.4500.0036.4511,5280.07%
2021/11/16142.9000.0045.0011,5030.07%
2021/11/15139.6000.0040.9511,4920.07%
2021/11/05143.05143.0543.0501,5010.00%
2021/11/04349.93947.8047.80-61,457-0.41%
2021/10/141134.0000.00134.0011,3570.07%
2021/10/0800.001125.50124.00-11,328-0.08%
2021/10/0500.002124.25140.00-21,283-0.16%
2021/10/041142.0016.5133.80129.50-15.51,235-1.25%
2021/09/3000.001134.50132.00-11,148-0.09%
2021/09/291117.5000.00130.5011,0980.09%
2021/09/280.5115.0000.00119.000.51,0630.05%
2021/09/2400.002118.50118.50-21,012-0.20%
2021/09/232108.0000.00108.0029770.20%
2021/09/161108.5000.00109.0019250.11%
2021/09/1400.0015108.00103.00-15832-1.80%
2021/09/1300.00598.2098.20-5754-0.66%
2021/09/0900.00189.9089.10-1715-0.14%
2021/09/08190.1000.0088.5017110.14%
2021/08/2600.001195.4192.10-11581-1.89%
2021/08/25190.8000.0087.5015350.19%
2021/08/1800.00285.0082.00-2470-0.43%
2021/08/13389.10894.0191.00-5420-1.19%
2021/07/28349.2500.0049.2032801.07%
2021/07/23248.4000.0048.3522750.73%
2021/07/15346.3500.0046.9032741.09%
2021/07/08448.5500.0048.5042761.45%
2021/06/2100.00148.5548.55-1332-0.30%
2021/06/1600.00149.8049.40-1333-0.30%
2021/06/09450.1800.0050.0043311.21%
2021/06/07350.2000.0050.0033320.90%
2021/05/27249.9500.0050.0023340.60%
2021/05/1700.00556.6657.60-5401-1.25%
2021/05/13457.25658.6059.50-2371-0.54%
2021/05/12753.9300.0054.4073472.02%
2021/05/1000.00151.0050.70-1324-0.31%
2021/05/07351.1000.0051.1033230.93%
2021/04/27157.3000.0057.0013060.33%
2021/04/23156.0000.0055.4013000.33%
2021/04/22255.3000.0055.5023010.66%
2021/04/16255.6000.0055.6022960.67%
2021/02/2300.00154.3051.60-1266-0.37%
2021/02/22154.3000.0054.3012670.37%
2021/02/02240.5000.0042.0022440.82%
2021/01/29340.4500.0039.9532441.23%
2021/01/13344.1500.0044.1032601.15%
2021/01/11544.1000.0044.1052651.88%
2020/12/24245.5500.0045.5022720.73%
2020/12/2200.00145.0049.50-1266-0.38%
2020/12/21245.2500.0045.0022630.76%
2020/12/14246.1000.0045.9522880.69%
2020/12/0900.00145.5045.35-1330-0.30%
2020/12/03148.3000.0047.3513480.29%
2020/11/26147.9000.0047.5013720.27%
2020/11/25149.2000.0048.7013760.27%
2020/11/24149.7000.0048.5013790.26%
2020/11/1800.00249.5050.10-2378-0.53%
2020/11/16145.3500.0045.4013850.26%
2020/10/28250.9500.0050.4025750.35%
2020/10/1300.00155.9055.90-1661-0.15%
2020/10/05259.25160.0059.3017250.14%
2020/09/24163.9000.0061.5017560.13%
2020/09/21266.00165.0065.0017830.13%
2020/09/0700.00169.1067.10-1925-0.11%
2020/08/31178.0000.0077.2019460.11%
2020/08/27179.9000.0080.0019390.11%
2020/08/2600.00178.3082.30-1928-0.11%
2020/08/25174.5000.0074.9019170.11%
2020/08/06291.60397.0086.20-1824-0.12%
2020/08/04182.0000.0082.5017650.13%
2020/07/3100.00172.2072.20-1738-0.14%
2020/07/21166.5000.0066.5016670.15%
2020/07/17292.5000.0081.9026260.32%
2020/07/1500.005100.90100.50-5597-0.84%
2020/07/1000.001138.00137.00-1552-0.18%
2020/07/03197.1000.0097.1014980.20%
2020/07/0100.00280.3080.30-2468-0.43%
2020/06/30270.2000.0073.0024450.45%
2020/06/24267.8000.0068.5024250.47%
2020/06/23276.0000.0072.1024070.49%
2020/06/19174.1000.0067.9013570.28%
2020/06/111057.50158.6056.7092253.99%
2020/06/10154.202053.4554.40-19182-10.43%
2020/06/0800.00543.7545.00-5143-3.48%
2020/06/0100.001038.8039.50-10116-8.60%
2020/05/2700.00134.6036.15-1100-0.99%
2020/05/2600.001037.6036.00-1097-10.24%
2020/05/2500.001535.3535.35-1587-17.23%
2020/05/2100.00531.9032.10-576-6.57%
2020/05/15130.9000.0030.901681.47%
2020/05/112028.8000.0029.50206331.41%
2020/05/0800.002532.0032.00-2555-44.82%
2020/04/3000.00127.7028.10-136-2.73%
2020/04/27126.4000.0026.451362.75%
2020/01/0900.00129.8029.80-131-3.22%
2020/01/0700.00129.3029.10-131-3.18%
2019/07/24530.1500.0032.305628.02%
2019/07/22129.6000.0029.601511.95%
2019/07/0900.00529.0029.00-549-10.18%
2019/03/0600.00228.6029.00-294-2.11%
2019/03/05229.1500.0029.102932.14%
2019/02/25528.0000.0028.105905.53%
2019/02/2100.001029.1028.85-1088-11.31%
2019/01/251027.3000.0027.35107014.22%
2019/01/2300.001728.2528.25-1759-28.81%
2018/12/271025.8500.0025.65104323.07%
2018/09/19730.3000.0029.0074515.46%
2018/06/29525.6000.0025.855608.24%
2018/05/04428.6000.0029.3541352.96%
2018/04/25528.1500.0028.5051353.69%
2018/04/23529.1000.0029.0551333.76%
2018/04/12530.1600.0030.1051263.96%
2018/04/10330.45130.7030.3021241.61%
2018/04/03230.5000.0030.6521191.68%
2018/04/02231.1000.0031.0021181.69%
2018/03/31330.5500.0030.9031152.59%
2018/03/30530.9100.0030.7551134.39%
2018/03/2900.00533.1032.50-5105-4.75%
2018/03/19330.1000.0032.903734.08%
2018/02/0800.00330.5731.00-349-6.02%
2018/02/07330.5200.0030.903466.39%
2018/01/2900.00129.5029.50-140-2.48%
杏國將在歐洲腫瘤內科學會亞洲年會 發表胰臟癌臨床結果UDN聯合新聞網-2022/09/25
杏國胰臟癌新藥三期試驗喊卡 待美FDA通知補件Anue鉅亨-2022/05/18
杏國 相關文章